Overview

Efficacy and Safety Study of Fosamax Plus D in Postmenopausal Women With Osteoporosis (0217A-263)

Status:
Completed
Trial end date:
2009-04-10
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy/safety of Fosamax Plus D
Phase:
Phase 4
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Alendronate
Calcium
Cholecalciferol